Stress Management and Resiliency Training Following Acute Myocardial Infarction

Cardiovascular Diseases Clinical Trial

Official title:

Total-Body PET Imaging to Understand the Physiology of Stress, Inflammation, and Meditation Following a Heart Attack

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05415735
• Other study ID #: 1787419
• Status: Completed
• Phase: N/A
• Start date: May 11, 2022
• Est. completion date: October 1, 2023

Study information

• Verified date: May 2024
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this pilot study is to use total body PET/CT imaging to examine the relationships between stress, amygdala activation, and arterial wall inflammation in participants before and after participating in a multi-modal stress reduction program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: October 1, 2023
• Est. primary completion date: December 8, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Concurrently enrolled in an observational study of patients who have had an acute myocardial infarction

• Score on PSS-10 of 14 or greater during screening

• Willing and able to access the internet to participate in the online SMART Program

Exclusion Criteria:

• Poorly controlled physical or mental health condition that would likely interfere with the ability to participate in SMART or ability to undergo PET scan

• Current daily practice of meditation of 10 minutes or more per day

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Heart Attack
• Myocardial Infarction

Intervention

Behavioral:
• Stress Management and Resiliency Training Program
This is a multimodal mind-body program designed to teach participants a variety of different strategies to reduce their physiologic stress response.

Locations

Country	Name	City	State
United States	University of California Davis	Sacramento	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in amygdala activation	change in radiotracer uptake in the amygdala with FDG-PET imaging from before to after the SMART Program	about 10 weeks